Trump administration crackdown on gender-affirming care targets hospitals
The Trump administration is taking a bold stance on restricting gender-affirming care for transgender youth in the United States. The Centers for Medicare and Medicaid Services have proposed two rules that would withhold federal funds from facilities offering gender-affirming care for trans minors, including puberty blockers, hormones, and surgery. The most stringent rule would prevent these facilities from receiving any federal funding from Medicare or Medicaid, effectively forcing many medical centers to stop providing this crucial care.
Additionally, the proposed rules aim to prohibit Medicaid and Children’s Health Insurance Program funds from being used for gender-affirming care for minors. The public will have a 60-day period to submit comments on these proposed funding rules before any potential changes are made or the rules are finalized. It remains unclear how long it will take for CMS to finalize these rules, but with a significant number of comments expected, the process could take months to a year.
This latest move by the Trump administration is part of a broader campaign to limit access to gender-affirming care for trans youth. The administration has been actively working to roll back transgender health care since early in President Trump’s term. Health Secretary Robert F. Kennedy Jr. emphasized the administration’s stance that therapy and social transition without medical intervention should be prioritized for trans children, despite opposition from healthcare providers who argue that gender-affirming care is essential and evidence-based.
Critics of the proposed rules, including the American Academy of Pediatrics, argue that these policies do not align with the current medical consensus and fail to address the healthcare needs of trans youth. The Department of Health and Human Services has also proposed reversing a Biden administration update to a landmark disability law that expanded the definition of disability to include gender dysphoria.
The proposed rules have sparked widespread condemnation from various organizations, including the Children’s Hospital Association and Physicians for Reproductive Health. While the administration claims that gender-affirming care is not healthcare and does not meet medical standards of care, advocates for trans rights and healthcare professionals argue that these services are essential and often life-saving.
The legal challenges to these proposed rules are expected to be significant, with potential arguments around arbitrary and capricious rulemaking, nondiscrimination laws, and constitutional protections. As the debate continues, there may be disruptions in accessing care for transgender minors, as health systems grapple with the uncertainty surrounding the proposed rules. Patient communities are already pushing back against the termination of gender-affirming care programs, with families in Connecticut and grassroots campaigns in Boston advocating for the reinstatement of these vital services.
